Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Park Ha Biological Technology Co EV-to-EBIT?
Park Ha Biological Technology CoBYAH +7.69%20 EV-to-EBIT is 0.52 as of Aug. 10, 2026, which is 96% below its 10-year median of 12.23. GuruFocus rates BYAH with a GF Score™ of 20/100. The stock has 2 warning signs investors should review. Among 1,557 Consumer Packaged Goods companies, Park Ha Biological Technology Co ranks better than 98.01% on this metric.
Park Ha Biological Technology Co (NAS:BYAH) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Park Ha Biological Technology Co's Enterprise Value for the quarter that ended in Apr. 2026 was $-0.07 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Park Ha Biological Technology Co's EBIT for the trailing twelve months (TTM) ended in Apr. 2026 was $-5.36 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Park Ha Biological Technology Co EV-to-EBIT Related Terms
Park Ha Biological Technology Co EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Household & Personal Products subindustry, Park Ha Biological Technology Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Park Ha Biological Technology Co EV-to-EBIT vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Park Ha Biological Technology Co's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Park Ha Biological Technology Co's EV-to-EBIT falls into.
Park Ha Biological Technology Co's current Enterprise Value is $-2.80 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Park Ha Biological Technology Co's EBIT for the trailing twelve months (TTM) ended in Apr. 2026 was $-5.36 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Park Ha Biological Technology Co (BYAH) has a EV-to-EBIT of 0.52 as of Aug. 10, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Park Ha Biological Technology Co and its competitors. This is 96% below median its historical median of 12.23. According to the industry distribution chart, Park Ha Biological Technology Co ranks #31 out of 1557 companies in the Consumer Packaged Goods industry, placing it in the top 2%.
Is Park Ha Biological Technology Co's EV-to-EBIT too high?
Park Ha Biological Technology Co's current EV-to-EBIT of 0.52 is 96% below median its 10-year median of 12.23. The Consumer Packaged Goods industry median EV-to-EBIT is 12.16. Park Ha Biological Technology Co's value of 0.52 is 95.7% below this industry median. Based on the distribution chart, Park Ha Biological Technology Co ranks #31 out of 1557 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Park Ha Biological Technology Co has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Park Ha Biological Technology Co's EV-to-EBIT compare to CAWW and NASO?
According to the Consumer Packaged Goods industry distribution chart, Park Ha Biological Technology Co ranks #31 out of 1557 companies for EV-to-EBIT. This places Park Ha Biological Technology Co in the top 2% of its industry — outperforming the majority of peers. The industry median EV-to-EBIT is 12.16. Park Ha Biological Technology Co's value of 0.52 is 95.7% below this benchmark. While the company's 10-year median is 12.23 vs. the industry median of 12.16, Park Ha Biological Technology Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Consumer Packaged Goods company?
The median EV-to-EBIT among Consumer Packaged Goods companies is 12.16, based on 1,557 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Park Ha Biological Technology Co's current EV-to-EBIT of 0.52 is 95.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Park Ha Biological Technology Co and its competitors. For the Consumer Packaged Goods industry, the median EV-to-EBIT is 12.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Park Ha Biological Technology Co's current EV-to-EBIT is 0.52, which is 96% below median its own 10-year median of 12.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Park Ha Biological Technology Co stock overvalued right now?
Park Ha Biological Technology Co (BYAH) has a current EV-to-EBIT of 0.52. The current EV-to-EBIT is 0.52, which is 96% below median its 10-year median of 12.23 and 95.7% below the Consumer Packaged Goods industry median of 12.16. Park Ha Biological Technology Co's overall GF Score™ is 20/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Park Ha Biological Technology Co (BYAH), the current EV-to-EBIT is 0.52 as of Aug. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Park Ha Biological Technology Co Ltd is engaged in developing its private skincare label, direct skincare products sales, and franchise alliances promotions. Its Park Ha brand focuses on providing solutions for problematic skin. The company's Operating Subsidiaries provide skincare and cosmetic products under its brand, Park Ha, in China. Its Operating Subsidiaries develop its proprietary beauty products and offer complementary after-sales beauty services in its physical stores.
20GF Score
Get the complete analysis for BYAH
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BYAH has been successfully added to your 
